| Aha SM Grundy, NJ Stone, AL Bailey, C Beam, KK Birtcher, RS Blumenthal, ... ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the …, 2018 | 6334 | 2018 |
| 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart … SM Grundy, NJ Stone, AL Bailey, C Beam, KK Birtcher, RS Blumenthal, ... Circulation 139 (25), e1082-e1143, 2019 | 3933 | 2019 |
| Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation JD Brunzell, M Davidson, CD Furberg, RB Goldberg, BV Howard, ... Journal of the American College of Cardiology 51 (15), 1512-1524, 2008 | 1517 | 2008 |
| Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses … RB Goldberg, MJ Mellies, FM Sacks, LA Moyé, BV Howard, WJ Howard, ... Circulation 98 (23), 2513-2519, 1998 | 1440 | 1998 |
| The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial TJ Orchard, M Temprosa, R Goldberg, S Haffner, R Ratner, S Marcovina, ... Annals of internal medicine 142 (8), 611-619, 2005 | 1270 | 2005 |
| 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology … SM Grundy, NJ Stone, AL Bailey, C Beam, KK Birtcher, RS Blumenthal, ... Circulation 139 (25), e1046-e1081, 2019 | 1166 | 2019 |
| A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia RB Goldberg, DM Kendall, MA Deeg, JB Buse, AJ Zagar, JA Pinaire, ... Diabetes care 28 (7), 1547-1554, 2005 | 1028 | 2005 |
| Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications RB Goldberg The Journal of Clinical Endocrinology & Metabolism 94 (9), 3171-3182, 2009 | 907 | 2009 |
| American Association of Clinical Endocrinologists' guidelines for management of dyslipidemia and prevention of atherosclerosis PS Jellinger, DA Smith, AE Mehta, O Ganda, Y Handelsman, ... Endocrine practice 18, 1-78, 2012 | 664 | 2012 |
| Long-term metformin use and vitamin B12 deficiency in the diabetes prevention program outcomes study VR Aroda, SL Edelstein, RB Goldberg, WC Knowler, SM Marcovina, ... The Journal of Clinical Endocrinology & Metabolism 101 (4), 1754-1761, 2016 | 627 | 2016 |
| Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists MH Davidson, CM Ballantyne, TA Jacobson, VA Bittner, LT Braun, ... Journal of clinical lipidology 5 (5), 338-367, 2011 | 434 | 2011 |
| Familial deficiency of apolipoproteins AI and C-III and precocious coronary-artery disease RA Norum, JB Lakier, S Goldstein, A Angel, RB Goldberg, WD Block, ... New England Journal of Medicine 306 (25), 1513-1519, 1982 | 368 | 1982 |
| Lipid disorders in diabetes RB Goldberg Diabetes care 4 (5), 561-572, 1981 | 360 | 1981 |
| Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects HE Bays, RB Goldberg, KE Truitt, MR Jones Archives of Internal Medicine 168 (18), 1975-1983, 2008 | 279 | 2008 |
| Prevalence and risk factors associated with the metabolic syndrome and dyslipidemia in White, Black, Amerindian and Mixed Hispanics in Zulia State, Venezuela H Florez, E Silva, V Fernández, E Ryder, T Sulbarán, G Campos, ... Diabetes research and clinical practice 69 (1), 63-77, 2005 | 258 | 2005 |
| Statins in the treatment of dyslipidemia in the presence of elevated liver aminotransferase levels: a therapeutic dilemma RM Calderon, LX Cubeddu, RB Goldberg, ER Schiff Mayo Clinic Proceedings 85 (4), 349-356, 2010 | 255 | 2010 |
| Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy RB Goldberg, VA Fonseca, KE Truitt, MR Jones Archives of internal medicine 168 (14), 1531-1540, 2008 | 245 | 2008 |
| Long‐term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study Diabetes Prevention Program Outcomes Study Research Group; prepared on ... Diabetic Medicine 30 (1), 46-55, 2013 | 238 | 2013 |
| Climate change and the integrity of science PH Gleick, RM Adams, RM Amasino, E Anders, DJ Anderson, ... Science 328 (5979), 689-690, 2010 | 238 | 2010 |
| Pioglitazone and rosiglitazone have different effects on serum lipoprotein particle concentrations and sizes in patients with type 2 diabetes and dyslipidemia MA Deeg, JB Buse, RB Goldberg, DM Kendall, AJ Zagar, SJ Jacober, ... Diabetes care 30 (10), 2458-2464, 2007 | 227 | 2007 |
